Results 151 to 160 of about 3,069,445 (313)

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Brillouin microscopy in cancer research: a review. [PDF]

open access: yesJ Biomed Opt
Falkner N   +7 more
europepmc   +1 more source

Additional file 1 of Diagnostic delay in soft tissue tumors: a single-center study of a university cancer center with a focus on health services research

open access: gold, 2022
Tobias M. Ballhause   +5 more
openalex   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Mapping the landscape of rural cancer research: a global bibliometric analysis. [PDF]

open access: yesCancer Causes Control
Nelson D   +10 more
europepmc   +1 more source

Supplementary Vignette 3 from Building Tools for Machine Learning and Artificial Intelligence in Cancer Research: Best Practices and a Case Study with the PathML Toolkit for Computational Pathology

open access: gold
Jacob Rosenthal   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy